KBC Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54K | Sell |
3,152
-543
| -15% | -$9.3K | ﹤0.01% | 1576 |
|
|
2025
Q1 | $236K | Sell |
3,695
-5
| -0.1% | -$319 | ﹤0.01% | 982 |
|
|
2024
Q4 | $450K | Buy |
3,700
+1,361
| +58% | +$166K | ﹤0.01% | 831 |
|
|
2024
Q3 | $292K | Buy |
2,339
+238
| +11% | +$29.7K | ﹤0.01% | 802 |
|
|
2024
Q2 | $332K | Buy |
2,101
+173
| +9% | +$27.3K | ﹤0.01% | 752 |
|
|
2024
Q1 | $250K | Buy |
1,928
+448
| +30% | +$58.1K | ﹤0.01% | 806 |
|
|
2023
Q4 | $143K | Hold |
1,480
| – | – | ﹤0.01% | 921 |
|
|
2023
Q3 | $179K | Buy |
+1,480
| New | +$179K | ﹤0.01% | 852 |
|
|
2021
Q4 | – | Sell |
-555
| Closed | -$51K | – | 1340 |
|
|
2021
Q3 | $51K | Sell |
555
-13,249
| -96% | -$1.22M | ﹤0.01% | 1238 |
|
|
2021
Q2 | $1.07M | Sell |
13,804
-74
| -0.5% | -$5.75K | ﹤0.01% | 860 |
|
|
2021
Q1 | $1.03M | Hold |
13,878
| – | – | ﹤0.01% | 863 |
|
|
2020
Q4 | $13M | Hold |
13,878
| – | – | 0.01% | 727 |
|
|
2020
Q3 | $1.95M | Sell |
13,878
-6,192
| -31% | -$870K | 0.01% | 717 |
|
|
2020
Q2 | $3.22M | Buy |
20,070
+12,085
| +151% | +$1.94M | 0.01% | 607 |
|
|
2020
Q1 | $781K | Buy |
7,985
+2,544
| +47% | +$249K | 0.01% | 752 |
|
|
2019
Q4 | $702K | Buy |
5,441
+3,341
| +159% | +$431K | ﹤0.01% | 1012 |
|
|
2019
Q3 | $158K | Buy |
2,100
+1,485
| +241% | +$112K | ﹤0.01% | 1288 |
|
|
2019
Q2 | $93K | Hold |
615
| – | – | ﹤0.01% | 1310 |
|
|
2019
Q1 | $73K | Buy |
+615
| New | +$73K | ﹤0.01% | 1293 |
|